Société Corvus Pharmaceuticals, Inc.
Actions
CRVS
US2210151005
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,16 USD | +2,37 % | +4,85 % | +22,73 % |
Métier
Nombre d'employés: 28
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27/01/14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21/07/22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | 55 | 06/02 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27/01/14 |
Ian Clark
BRD | Director/Board Member | 62 | 03/01/17 |
Terry Gould
BRD | Director/Board Member | 67 | 01/11/14 |
Peter Thompson
FOU | Founder | 64 | 27/01/14 |
Linda Grais
BRD | Director/Board Member | 68 | 28/01/19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01/12/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 62 551 281 | 56 761 695 ( 90,74 %) | 0 | 90,74 % |
Coordonnées société
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+22,73 % | 135 M | |
+43,36 % | 54,63 Md | |
-5,31 % | 39,92 Md | |
+37,52 % | 38,82 Md | |
+14,75 % | 26,86 Md | |
-12,56 % | 26,22 Md | |
-22,45 % | 18,78 Md | |
+25,12 % | 12,21 Md | |
+0,04 % | 12,16 Md | |
+26,04 % | 11,94 Md |
- Bourse
- Actions
- Action CRVS
- Société Corvus Pharmaceuticals, Inc.